Evidence map›Paper›PMID 28686836›Full record

ArticleAnalytical chemistry2017

Hydrophobic Patch of Ubiquitin is Important for its Optimal Activation by Ubiquitin Activating Enzyme E1.

Rajesh K Singh, Yaniv Kazansky, Donald Wathieu, David Fushman

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Molecular mechanisms underlying p62-dependent secretion of the Alzheimer-associated ubiquitin variant UBBProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Review
  3. Synthesis of SelectivelyChemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Post-translational Modifications of IκBα: The State of the Art.Frontiers in cell and developmental biology · 2020
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rajesh K SinghDepartment of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland , College Park, Maryland 20742, United States.
Yaniv KazanskyDepartment of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland , College Park, Maryland 20742, United States.
Donald WathieuDepartment of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland , College Park, Maryland 20742, United States.
David FushmanDepartment of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland , College Park, Maryland 20742, United States.ORCID 0000-0002-6634-8056
University of Maryland, College Park · US

Funding

Solution structure and dynamics of polyubiquitin chainsR01GM065334 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI DAVID FUSHMAN · 2002 to 2026
$6.2M
Ubiquitinated Proteins in Exosomes of Immune Suppressive Myeloid CellsR01GM021248 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI FENSELAU, CATHERINE C, FUSHMAN, DAVID · 1985 to 2017
$4.6M
Recognition of non-ubiquitin signals at the proteasomeR01GM095755 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI FUSHMAN, DAVID · 2011 to 2014
$1.4M
APPLICATIONS OF MASS SPECTROMETRY IN PHARMACOLOGYR37GM021248 · NIGMS · UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS · PI FENSELAU, CATHERINE C. · 1992 to 2001
$438k
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM021248NIGMS NIH HHS R01 GM065334NIGMS NIH HHS R01 GM095755NIGMS NIH HHS R37 GM021248
6 · The paper itself

Abstract

Protein ubiquitination plays a role in essentially every process in eukaryotic cells. The attachment of ubiquitin (Ub) or Ub-like (UBL) proteins to target proteins is achieved by parallel but distinct cascades of enzymatic reactions involving three enzymes: E1, E2, and E3. The E1 enzyme functions at the apex of this pathway and plays a critical role in activating the C-terminus of ubiquitin or UBL, which is an essential step that triggers subsequent downstream transfer to their cognate E2s resulting in the fidelity of the Ub/UBL conjugation machinery. Despite the central role of the E1 enzyme in protein modification, a quantitative method to measure Ub/UBL activation by E1 is lacking. Here, we present a mass spectrometry-based assay to accurately measure the activation of Ub/UBL by E1 independent of the E2/E3 enzymes. Our method does not require radiolabeling of any components and therefore can be used in any biochemical laboratory having access to a mass spectrometer. This method allowed us to dissect the concerted process of E1-E2-catalyzed Ub conjugation in order to separately characterize the process of Ub activation and how it is affected by select mutations and other factors. We found that the hydrophobic patch of Ub is important for the optimal activation of Ub by E1. We further show that the blockers of the Ub-proteasome system such as ubistatin and fullerenol inhibit Ub activation by E1. Interestingly, our data indicate that the phosphorylation of Ub at the S65 position augments its activation by the E1 enzyme.

Indexed as

EsterificationFullerenesHydrophobic and Hydrophilic InteractionsMutagenesis, Site-DirectedPhosphorylationQuinolinesSpectrometry, Mass, Electrospray IonizationSulfanilic AcidsSulfurUbiquitinUbiquitin-Activating EnzymesUbiquitinationFullerenesfullerenolQuinolinesSulfanilic AcidsSulfurUbiquitinUbiquitin-Activating Enzymesubistatin A

Identifiers

PMID28686836
PMCPMC5573600
OpenAlexW2724226211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.